Extracellular Nucleotides Induce Vasodilatation in Human Arteries Via Prostaglandins, Nitric Oxide and Endothelium-derived Hyperpolarising Factor

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2003 May 2

PMID 12721100

Citations 42

Authors

Anna-Karin Wihlborg

Malin Malmsjo

Atli Eyjolfsson

Ronny Gustafsson

Kenneth Jacobson

David Erlinge

Affiliations

Soon will be listed here.

Abstract

1. The present study was aimed at examining P2 receptor-mediated vasodilatation in human vessels. The isometric tension was recorded in isolated segments of the human left internal mammary artery branches precontracted with 1 microM noradrenaline. 2. Endothelial denudation abolished the dilator responses. 3. The selective P2Y(1) agonist, 2-MeSADP, induced a potent vasodilatation (pEC(50)=6.9+/-0.1). The P2Y(1) antagonist of 10 microM, MRS 2216, shifted the 2-MeSADP concentration-response curve 1.1 log units to the right. The combined P2Y(1) and P2X agonist, 2-MeSATP, stimulated a dilatation with a potency similar to that of 2-MeSADP. Furthermore, MRS 2216 had a similar antagonistic effect on both 2-MeSATP and 2-MeSADP indicating that P2X receptors do not mediate vasodilatation. 4. Both the P2Y(2/4) agonist, UTPgammaS and the P2Y(6) agonist, UDPbetaS, stimulated potent dilatations (pEC(50)=7.8+/-0.4 for UTPgammaS and 8.4+/-0.2 for UDPbetaS). 5. The 2-MeSADP-induced nitric oxide (NO)-mediated dilatation was studied in the presence of 10 micro M indomethacin, 50 nM charybdotoxin and 1 microM apamin. The involvement of the endothelium-derived hyperpolarising factor (EDHF) was investigated in the presence of 0.1 mM L-NOARG and indomethacin. The involvement of prostaglandins was investigated in the presence of L-NOARG, charybdotoxin and apamin. Both NO, EDHF and prostaglandins mediated 2-MeSADP dilatation with similar efficacy (E(max)=25+/-5% for NO, 25+/-6% for EDHF and 27+/-5% for prostaglandins). 6. In conclusion, extracellular nucleotides induce endothelium-derived vasodilatation in human vessels by stimulating P2Y(1), P2Y(2/4) and P2Y(6) receptors, while P2X receptors are not involved. Endothelial P2Y receptors mediate dilatation by release of EDHF, NO and prostaglandins.

Citing Articles

Oral ATP treatment in alternating hemiplegia of childhood: a case report and review.

Carrozzi M, Morelli M, Cirino M, Maestro A, Paternuosto G, Benericetti G Front Med (Lausanne). 2025; 11():1433217.

PMID: 39839618 PMC: 11747781. DOI: 10.3389/fmed.2024.1433217.

THE effect of P2X7 receptor activation on functional responses of human left internal mammary artery.

Bayram Z, Akcabag E, Ozbey G, Nacitarhan C, Ozdem S, Turkay C Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):2027-2037.

PMID: 39225832 DOI: 10.1007/s00210-024-03411-1.

How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.

Dales M, Drummond R, Kennedy C Purinergic Signal. 2024; .

PMID: 38740733 DOI: 10.1007/s11302-024-10016-z.

Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats.

Miguel-Martinez A, Linares-Bedolla J, Villanueva-Castillo B, Haanes K, MaassenVanDenBrink A, Villalon C Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986572 PMC: 10056196. DOI: 10.3390/ph16030475.

Pleiotropic effects of clopidogrel.

Kuszynski D, Lauver D Purinergic Signal. 2022; 18(3):253-265.

PMID: 35678974 PMC: 9391547. DOI: 10.1007/s11302-022-09876-0.

References

Rump L, Oberhauser V, von Kugelgen I . Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms. Kidney Int. 1998; 54(2):473-81. DOI: 10.1046/j.1523-1755.1998.00002.x. View

Yamamoto K, Korenaga R, Kamiya A, Ando J . Fluid shear stress activates Ca(2+) influx into human endothelial cells via P2X4 purinoceptors. Circ Res. 2000; 87(5):385-91. DOI: 10.1161/01.res.87.5.385. View

Corriu C, Feletou M, Canet E, Vanhoutte P . Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol. 1996; 119(5):959-64. PMC: 1915922. DOI: 10.1111/j.1476-5381.1996.tb15765.x. View

Malmsjo M, Erlinge D, Hogestatt E, Zygmunt P . Endothelial P2Y receptors induce hyperpolarisation of vascular smooth muscle by release of endothelium-derived hyperpolarising factor. Eur J Pharmacol. 1999; 364(2-3):169-73. DOI: 10.1016/s0014-2999(98)00848-6. View

Communi D, Govaerts C, Parmentier M, Boeynaems J . Cloning of a human purinergic P2Y receptor coupled to phospholipase C and adenylyl cyclase. J Biol Chem. 1998; 272(51):31969-73. DOI: 10.1074/jbc.272.51.31969. View

Satterwhite C, Farrelly A, Bradley M . Chemotactic, mitogenic, and angiogenic actions of UTP on vascular endothelial cells. Am J Physiol. 1999; 276(3):H1091-7. DOI: 10.1152/ajpheart.1999.276.3.H1091. View

Malmsjo M, Hou M, Harden T, Pendergast W, Pantev E, Edvinsson L . Characterization of contractile P2 receptors in human coronary arteries by use of the stable pyrimidines uridine 5'-O-thiodiphosphate and uridine 5'-O-3-thiotriphosphate. J Pharmacol Exp Ther. 2000; 293(3):755-60. View

Ralevic V, Burnstock G . Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50(3):413-92. View

Kunapuli S, Daniel J . P2 receptor subtypes in the cardiovascular system. Biochem J. 1998; 336 ( Pt 3):513-23. PMC: 1219898. DOI: 10.1042/bj3360513. View

10.

Malmsjo M, Bergdahl A, Zhao X, Sun X, Hedner T, Edvinsson L . Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res. 1999; 43(1):200-9. DOI: 10.1016/s0008-6363(99)00062-0. View

11.

Liu Z, Ge Z, He G . Difference in endothelium-derived hyperpolarizing factor-mediated hyperpolarization and nitric oxide release between human internal mammary artery and saphenous vein. Circulation. 2000; 102(19 Suppl 3):III296-301. DOI: 10.1161/01.cir.102.suppl_3.iii-296. View

12.

Fujii K, Tominaga M, Ohmori S, Kobayashi K, Koga T, Takata Y . Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992; 70(4):660-9. DOI: 10.1161/01.res.70.4.660. View

13.

Ray F, Huang W, Slater M, Barden J . Purinergic receptor distribution in endothelial cells in blood vessels: a basis for selection of coronary artery grafts. Atherosclerosis. 2002; 162(1):55-61. DOI: 10.1016/s0021-9150(01)00681-5. View

14.

Lazareno S, Birdsall N . Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equations. Br J Pharmacol. 1993; 109(4):1110-9. PMC: 2175764. DOI: 10.1111/j.1476-5381.1993.tb13737.x. View

15.

Hou M, Harden T, Kuhn C, Baldetorp B, Lazarowski E, Pendergast W . UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors. Am J Physiol Heart Circ Physiol. 2002; 282(2):H784-92. DOI: 10.1152/ajpheart.00997.2000. View

16.

Brown S, King B, Kim Y, Jang S, Burnstock G, Jacobson K . Activity of Novel Adenine Nucleotide Derivatives as Agonists and Antagonists at Recombinant Rat P2X Receptors. Drug Dev Res. 2012; 49(4):253-259. PMC: 3393598. DOI: 10.1002/1098-2299(200004)49:4<253::AID-DDR4>3.0.CO;2-1. View

17.

Hansmann G, Ihling C, Pieske B, Bultmann R . Nucleotide-evoked relaxation of human coronary artery. Eur J Pharmacol. 1998; 359(1):59-67. DOI: 10.1016/s0014-2999(98)00572-x. View

18.

Nicholas R, Watt W, Lazarowski E, Li Q, Harden K . Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol. 1996; 50(2):224-9. View

19.

von Albertini M, Palmetshofer A, Kaczmarek E, Koziak K, Stroka D, Grey S . Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochem Biophys Res Commun. 1998; 248(3):822-9. DOI: 10.1006/bbrc.1998.9055. View

20.

Hogestatt E, Andersson K, Edvinsson L . Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 1983; 117(1):49-61. DOI: 10.1111/j.1748-1716.1983.tb07178.x. View